Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2004International Journal of Technology Assessment in Health Care

Thrombolytic agent usage in England took 8 years to reach the clinical need ceiling, resulting in an estimated shortfall of 167,800 doses (95% CI 94,000 to 241,700) over 14 years.

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with acute myocardial infarction in England from 1981 to 2000

Design

Other

Follow-up

1981 to 2000

Key result

Thrombolytic agent usage in England took 8 years to reach the clinical need ceiling, resulting in an estimated shortfall of 167,800 doses (95% CI 94,000 to 241,700) over 14 years.

Authors

CPClaire PackerASAndrew StevensACAlison Cook

Discussion

Loading...

Member takes

Overview

Delayed thrombolytic uptake may indicate under-treatment in England; leaves open strategies to accelerate adoption of proven therapies.

Study Design

Type

Observational

Structured PICO

P
Population
National sales and use data of thrombolytic agents for acute myocardial infarction in England from 1980 to 2000.
E
Exposure
Thrombolytic agents
O
Outcome
Adoption and take up of thrombolytic agents compared with estimated ceiling of clinical need

Main Result

Effect estimate: 167,800 doses (95% CI 94,000 to 241,700)

Despite rapid initial uptake, it took 8 years for thrombolysis usage to reach the clinical need ceiling in England, highlighting the need to monitor the adoption of cost-effective innovations.

Cite This Study

Packer et al. (2004) conducted an observational in acute myocardial infarction. Thrombolytic agents vs. Estimated clinical need was evaluated on Shortfall in doses resulting from the difference between estimated ceiling of clinical need and doses purchased and provided (167,800 doses, 95% CI 94,000 to 241,700). Thrombolytic agent usage in England took 8 years to reach the clinical need ceiling, resulting in an estimated shortfall of 167,800 doses (95% CI 94,000 to 241,700) over 14 years.

synapsesocial.com/papers/6a7da3986ef7ec97ba7d867chttps://doi.org/10.1017/s0266462304001461
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: Case study2004 · 3 citations
  2. 2Reduced in-hospital mortality from acute myocardial infarction with general adoption of thrombolytic treatment in the North West Thames health region 1979-1991.1995 · 25 citations
  3. 3Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.1995 · 18 citations
  4. 4A Nationwide Survey of Prescribing Patterns for Thrombolytic Drugs in Acute Myocardial Infarction1990 · 4 citations
  5. 5Trends in the provision of thrombolytic treatment between 1993 and 19971999 · 38 citations